Press release
Global Clinical Trials Market Estimated $1.76 Billion Growth by 2025 | A report by Clinipace Worldwide, LabCorp, Eli Lilly and Company, ICON Plc., Novo Nordisk, Parexel, Pfizer Inc., Pharmaceutical Product Development and others
Market Analysis:
The Global Clinical Trials Market is expected to reach USD 1.76 billion by 2025, from USD 1.04 billion in 2017 growing at a CAGR of 6.7% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Download Sample PDF Report https://databridgemarketresearch.com/request-a-sample/?dbmr=global-clinical-trials-market
Key Players:
• Clinipace Worldwide
• LabCorp
• Eli Lilly and Company
• ICON Plc.
• Novo Nordisk
• Parexel
• Pfizer Inc.
• Pharmaceutical Product Development
• LLC
• IQVIA
• Roche Holding
• Ranbaxy Laboratories.Ltd
• Sanofi Aventis A.S. and Roche Group.
• Aaipharma Services Corp
• Accell Clinical Research LLC
• Aptiv Solutions
• Chiltern International Limited
• Congenix
• Covance Inc.
• Ecron Acunova Ltd
• Eurotrials
• Medpace Inc
• Pharmanet Development Group
• PRA International
• Siro Clinpharm PVT. LTD among others
Key Developments in the Market:
• In March 2016, AAIPharma Services Corporation, which is a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, announced its new identity as a leading contract development and manufacturing organization (CDMO) with expanded capabilities and capacity, the organization to now be known as “Alcami”
• In July2018, Boehringer Ingelheim and Lilly announce Tradjenta’s CARMELINA cardiovascular outcome trial meets primary endpoint. The company announced the positive top-line results from the trial, which evaluated the impact of treatment with Tradjenta compared with placebo on cardiovascular safety on top of standard of care.
Get Detailed TOC https://databridgemarketresearch.com/toc/?dbmr=global-clinical-trials-market
Major Market Drivers and Restraints:
• Demand for clinical trials in emerging markets
• High R&D spending of the pharmaceutical industry
• Increasing prevalence of diseases
• Focus on rare diseases and multiple orphan drugs in pipeline
• Lack of skilled clinical research workforce
• Regulatory quality in emerging markets
• Stringent regulations for patient enrollment
Market Segmentation:
The global clinical trials market is segmented based on
• Phase
• Design
• Geographical segments
Phase
Phase I
Phase II
Phase III
Phase IV
Design
• treatment studies
• observational studies
Treatment studies
• randomized control trial
• adaptive clinical trial
• non-randomized control trial
Observational studies
• cohort study
• case control study
• cross sectional study
• ecological study
Geography
• North America
• South America
• Europe
• Asia-Pacific
• Middle East
• Africa
Competitive Analysis:
The global clinical trials market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Clinical trials market for global, Europe, North America, Asia Pacific and South America.
Speak to Author https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-clinical-trials-market
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Clinical Trials Market Estimated $1.76 Billion Growth by 2025 | A report by Clinipace Worldwide, LabCorp, Eli Lilly and Company, ICON Plc., Novo Nordisk, Parexel, Pfizer Inc., Pharmaceutical Product Development and others here
News-ID: 1714400 • Views: …
More Releases from Data Bridge Market Research
Tumor Immunotherapy Market to Grow at a CAGR of 9.7% by 2028 | Industry Trends, …
Data Bridge Market Research analyses that the market to reach at an estimated value of USD 137.45 billion by 2028 and is growing with the CAGR of 9.7% in the forecast period of 2021 to 2028.
Tumor immunotherapy is a generally a procedure for treating tumors by modifying the ability of their immune system and their ability to fight against these tumors. This procedure provides the immune system with the ability…
External Ventricular Drain Market to Grow at a CAGR of 5.2% by 2031 | Industry T …
Data Bridge Market Research analyzes that the global external ventricular drain market which was USD 2,777.28 million in 2023, will reach USD 4,166.25 million by 2031, and is expected to undergo a CAGR of 5.2% during the forecast period.
External Ventricular Drain (EVD), also referred to as an external ventricular drainage (EVD) system or a ventriculostomy is used in neurosurgery to remove Extra Cerebrospinal Fluid (CSF) from the ventricles of the…
Injection Pen Market to Grow at a CAGR of 6.87% by 2029 | Industry Trends, Size, …
Injection pen market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 6.87% in the above-mentioned forecast period.
Injection pens are basically the medical instrument that are utilized for inserting the medicine or injecting the insulin into the patient's body. The injection pens generally consists a medical cartridge (insulin cartridge), a disposable pen,…
Modular Laboratory Automation Market to Exhibit a Remarkable CAGR of 6.76% by 20 …
The global modular laboratory automation market size was valued at USD 8.98 billion in 2024 and is projected to reach USD 15.15 billion by 2032, with a CAGR of 6.76% during the forecast period of 2025 to 2032.
Market Definition:
Modular Laboratory Automation refers to a flexible and customizable system designed to automate various laboratory processes by using interchangeable and scalable modules. These modules can be combined and configured to perform specific…
More Releases for Clinical
Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia."
Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures.
Developments in Testing and Preference for Evidence based testing: There is also a rising number…
Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice.
smaller2
Easily access patient
information
Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it.
Medical billing software innovation
Become a paperless
practice
Create scripts, sick notes, and clinical notes electronically. Plus, have…
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation.
This is the premier interdisciplinary forum for…
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018
When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral…
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.…
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry.
The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical…
